
## **Trustees’ Annual Report for the period** 

**From  1.4.23              Period start date   To 30.06.24    Period end date Charity name: Forgotten Patients, Overlooked Diseases** 

## **Charity registration number: 1202442** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The Trustees of Forgotten Patients, Overlooked<br>Diseases (FPOD) present their annual report and<br>accounts for the first 15 months of the CIO’s<br>existence, and confirm that reporting complies with<br>FPOD’s governing document, Charities SORP (FRS<br>102), and relevant legislation.<br>FPOD aims to develop resources for people with<br>medically unexplained symptoms (MUS), overlooked<br>health issues, or common unresolved health<br>problems; provide support/signposting for patients &<br>families not being helped elsewhere; facilitate or<br>deliver research, and support the dissemination and/<br>or application of the useful results of such, for the<br>public benefit; promote knowledge in, and advance<br>knowledge of medically unexplained symptoms,<br>overlooked health issues, or common unresolved<br>health problems. The term “overlooked diseases”<br>refers to conditions for which there may be limited<br>medical education or interest among healthcare<br>professionals, providers, researchers, industry or<br>government bodies.<br>FPOD helps people with complex symptoms to find a<br>diagnosis and access support. Modern healthcare can<br>do so much, yet some people with undiagnosed<br>complex symptoms may not receive potentially<br>beneficial health interventions. Even people with<br>common diseases can be overlooked. Organizations<br>exist to support individuals with specific rare<br>diseases, but those with unrecognised or incorrectly<br>categorised diseases lack the support that disease-<br>specific organizations can provide.<br>FPOD’s charitable activities aim to change that<br>situation, by<br>• developing practical, accessible resources for<br>people trying to cope with the uncertainty of<br>overlooked health issues<br>• providing support/signposting for patients and<br>families who are not being helped elsewhere<br>• facilitating, sponsoring or delivering research<br>• promoting education<br>• encouraging the adoption of research findings.|





|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|FPOD’s activities  focussed on advancing knowledge<br>of MUS, for those personally affected by MUS, and<br>for their  healthcare providers. As well as helping to<br>raise general awareness of MUS and the often<br>protracted search for diagnosis  experienced by some<br>patients, FPOD’s activities increased the visibility of<br>the charity, and generated significant feedback.<br>Activities included -<br>• free educational webinar “Forgotten Patients,<br>Overlooked Diseases and Lost Health Solutions”.<br>• “Medically Unexplained Symptoms” conference<br>• publications in professional journals<br>• production of a patient guide “How to make the<br>most of your GP visit”<br>• a survey relating to hyper-mobility<br>• Engagement with EURORDIS (European<br>Organisation for Rare Diseases<br>_Note: MUS is the term used in FPOD’s Constitution._<br>_However there are other terms, such as persistent_<br>_physical symptoms (PPS), used with reference to the_<br>_long journey in search of diagnosis, which is_<br>_experienced by some patients._|
|---|---|---|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|In setting objectives, trustees considered the Charity<br>Commission’s guidance on public benefit. FPOD’s<br>charitable activities benefit those affected by<br>medically unexplained symptoms, overlooked health<br>issues, or common unresolved health problems. As<br>well as individuals who are personally affected, this<br>includes their families and/or carers, and medical<br>professionals involved in their treatment.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

||SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38|Grant-making is not part of FPOD’s charitable aims/<br>activities.|
|Policy on social investment<br>including program related<br>investment|Para 1.38|Social investment is not part of  FPOD’s charitable<br>aims/activities|
|Contribution made by<br>volunteers|Para 1.38|FPOD values the contribution made by volunteers,<br>who are essential to the charity’s operation. 78<br>volunteers gave c.2000 hours to FPOD. A breakdown<br>of the estimated hours is in the Annual Report. This<br>does not give economic value to their contribution,<br>but illustrates that FPOD could not provide projects<br>or activities without the input of volunteers.<br>FPOD volunteers include health and social care<br>professionals, scientists, academics, ethicists, and<br>people with medical conditions.|
|Other|||





## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|• “Medically Unexplained Symptoms”: conference,<br>addressing the impact of MUS on healthcare<br>providers, and patients trying to navigate the<br>healthcare system.<br>• Patient Guide: make the most of your GP visit.<br>• “Forgotten Patients, Overlooked Diseases and Lost<br>Health Solutions”: educational webinar<br>• Presentations at the Institute of Medical Ethics<br>Annual Conference “Being Heard”<br>• established contact with bodies such as the<br>Community Engagement Task Force (CETF)<br>initiated by EURORDIS (European Organization<br>for Rare Diseases). CETF is a multi-stakeholder<br>group of  scientists and clinicians.<br>• The Zebra Survey: issues around hyper-mobility<br>**Publications**:<br>• Noble B, Tookman A, Schmechel C, Stephens R,<br>Oesterling C, Jani K, Speck P, Diehl-Wiesenecker<br>E, Chrysostomou K, Walker S. The Challenge of<br>Diseases and Forgotten Patients. RCGP Life,<br>12thAugust 2022. http://bit.ly/3A8ryua (accessed<br>1st November 2022)<br>• Lifschitz, Carlos MD*; Walker, StevenMD†;<br>Tookman, Adrian MD‡. Awareness of Tissue<br>Disorders and Functional Gastrointestinal Diseases.<br>Journal of Pediatric Gastroenterology and Nutrition<br>77(6):p e115, December 2023. | DOI: 10.1097/<br>MPG.0000000000003947<br>• Goa, Ivy; Jani, Kiran; Patel, Chantal; Oesterling,<br>Christine; Tookman, Adrian; Walker, Steven.<br>Update on rare diseases and genetic testing. RCGP<br>Life (published 17thFebruary 2024) http://<br>tinyurl.com/3uzvzz6c<br>• Forrest, Christianne; Speck, Peter; Rajput-Ray,<br>Minha; Tookman, Adrian; Walker, Steven.<br>Medically unexplained symptoms: Four<br>perspectives. RCGP Life (published 4thMarch<br>2024)  https://shorturl.at/zrXdh<br>• Tookman, A; Verma, J; Forrest, C; Chrysostomou,<br>K; Stephens, R; Walker, S. Rapid Response to<br>Richards T. BMJ Opinion: Not “all in the mind”.<br>BMJ 2024; 385:q1210. https://shorturl.at/6kcCk<br>**Abstracts/posters**<br>**S**amira Nur, James Coultas, Louise Jones, Christine<br>Oesterling, Adrian Tookman, Steven Walker, British<br>Journal of General Practice 2024; 74(suppl<br>1): bjgp24X738093. DOI: 10.3399/bjgp24X738093<br>Activities have elicited significant feedback,<br>demonstrating  the impact of these pieces of work,<br>and expanded FPOD’s visibility to other groups who<br>are working in this area. It is hoped that this will lead<br>to FPOD being able to develop appropriate resources<br>in the future, for forgotten patients and people with<br>overlooked diseases.|



You may choose to include further statements where relevant about: 

**Additional information (optional)** 



||Achievements against<br>objectives set<br>Para 1.41<br>FPOD’s main objectives for the first 2 years of<br>operation are :<br>• to raise the visibility of FPOD among those whose<br>lives are affected by overlooked health issues, so<br>that they recognise FPOD as a reliable source of<br>support and signposting;<br>• to establish & maintain FPOD’s reputation among<br>healthcare professionals  & providers, researchers,<br>industry, government bodies. This may be achieved<br>by delivering research encouraging the adoption of<br>research findings.<br>The response to events and publications indicates that<br>FPOD is meeting its objectives.<br>Performance of fundraising<br>activities against objectives<br>set<br>Para 1.41<br>No specific objectives were set, for fundraising<br>activities. The one-day conference on 1.5.24<br>produced some income from ticket sales, but the<br>primary intention was to ensure that as many people<br>as possible had access to the wide-ranging discussion<br>of topics on the programme.<br>Investment performance<br>against objectives<br>Para 1.41<br>Not applicable<br>Other|
|---|---|





## **Financial Review** 

|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|FPOD’s accounts have not been independently<br>examined, as income has been less than £25,000.<br>At the end of the reporting period, FPOD’s financial<br>situation was in deficit, due to expenditure on the<br>one-day conference which took place on 1.5.24. An<br>interest-free loan  of £1500 was made to FPOD by St<br>Gilesmedical Ltd, to pay the deposit relating to the<br>conference. St Gilesmedical was subsequently<br>appointed to act as as an agent for FPOD, paying<br>other costs relating to the conference directly: those<br>costs totalled £3617. The total interest-free loan was<br>£5117, of which £525 has been repaid. The remaining<br>debt of £4592 will be repaid in instalments, over a<br>period of 36 months. £420.69 was retained in<br>FPOD’s current account., to meet any minor<br>expenditure.<br>Trustees are aware of concerns about a loan from a<br>trustee, and have taken steps to protect the charity:<br>• Confirmed FPOD’s Constitution permitted the<br>borrowing;<br>• Concluded that the loan was necessary, as the<br>conference would enable FPOD to carry out its<br>charitable purposes more effectively;<br>• Recognized the potential conflict of interest,<br>implicit in accepting a loan from another trustee,<br>and will abide by FPOD’s Conflict of Interest<br>policy and Risk Management policy;<br>• The loan totalling £5117 is documented, and will<br>be repaid in instalments. Repayment in full should<br>be completed within 36 months of 1.5.24;<br>• Trustee Dr Steven Walker, Scientific Director of St<br>Gilesmedical, will absent himself from discussion<br>relating to the debt, and has added the loan to his<br>Declaration of Interests. All trustees ensure that<br>their declaration is updated  to reflect any changes<br>in their situation, which may affect FPOD.|
|---|---|---|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|FPOD’s future reserves policy will reflect the<br>intention to hold reserves sufficient to allow<br>FPOD to continue operating for a minimum of 3<br>months, in the event of an unplanned closure, so<br>that essential services are maintained for<br>beneficiaries, until alternative support is located.|
|Amount of reserves held|Para 1.22|Nil|
|Reasons for holding zero<br>reserves|Para 1.22|FPOD has not secured sufficient income, to be able<br>to allocate any amount, for reserves. At present,<br>FPOD has no regular overheads, as the charity has<br>neither premises nor employees.|
|Details of fund materially in<br>deficit|Para 1.24|As detailed above, FPOD’s financial situation<br>was in deficit at the end of the reporting period,<br>with a debt of £4592 owed to St Gilesmedical.|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|Trustees do not believe that there is any<br>uncertainty about FPOD’s future as a going<br>concern.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 



||The charity’s principal<br>sources of funds (including<br>any fundraising)<br>Para 1.47<br>Investment policy and<br>objectives including any<br>social investment policy<br>adopted<br>Para 1.46<br>FPOD does not have an investment or social<br>investment policy<br>A description of the principal<br>risks facing the charity<br>Para 1.46<br>The main risk facing FPOD is the difficulty of<br>securing income. This does not threaten FPOD’s<br>existence as such, as FPOD currently has no<br>regular overheads, but it could restrict<br>possibilities for growth and development. We<br>need to secure core  funding, so that FPOD has<br>some operating stability.<br>Trustees are seeking someone to take a lead on<br>fundraising, as a member of the board of trustees<br>Other|
|---|---|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:||FPOD is an independent charity without a parent<br>body or subsidiary bodies, not part of any wider<br>group structure. FPOD is a CIO with voting<br>members other than its trustees. Membership is<br>open to anyone who is interested in furthering<br>FPOD’s purposes.<br>FPOD aims to develop resources for people with<br>medically unexplained symptoms, overlooked<br>health issues or common unresolved health<br>problems, by<br>• developing practical, accessible resources for<br>people trying to cope with the uncertainty of<br>overlooked health issues<br>• providing support/signposting for patients and<br>families who are not being helped elsewhere<br>• facilitating, sponsoring or delivering research<br>• promoting education<br>• encouraging the adoption of research findings.|
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|FPOD’s governing document is a Constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|FPOD is constituted as a CIO.|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|FPOD welcomes expressions of interest, about<br>becoming a trustee. After initial discussion  with<br>the Chair & trustees, 1) to ensure the applicant is<br>eligible to be a trustee, and not disqualified from<br>trusteeship, by any provisions in FPOD’s<br>Constitution, or the Charities Act 2011; 2) to<br>ensure that the applicant understands the<br>functions and duties of a charity trustee. To that<br>end, the applicant would be provided with<br>FPOD’s Constitution, FPOD Trustees Code of<br>Conduct, and the most recent Annual Report &<br>Accounts. That would enable the applicant to<br>make an informed decision, whether they want<br>to proceed.<br>At the AGM, members would be invited to vote<br>on the appointment as a trustee, of the applicant.<br>No external body or individual is entitled to<br>appoint any FPOD trustees.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51|• Trustees’ Code of Conduct<br>• Trustees’ Conflict of Interests Policy &<br>Procedure<br>• Finance Policy (including Trustee Expenses)<br>• Risk Management Policy|
|---|---|---|





|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51|With no employees yet, FPOD trustees are gradually<br>assembling a structure that will allow the charity to<br>develop in the future, when finances permit.<br>FPOD works closely with the Forgotten Patients,<br>Overlooked Diseases Advisory Forum,  a  multi-<br>disciplinary group of health and social care<br>professionals, public health experts, academics,<br>scientists, ethicists, people with illness or medical<br>conditions, spiritual care-givers, politicians, and<br>campaigners with an international perspective. The<br>Forum meets remotely, once a month.<br>“Forgotten Patients, Ideas and Diseases Group” (as<br>the FPOD Advisory Forum was initially known) was<br>formed in early 2021, with 19 founding members: the<br>Group developed into an innovative international<br>network with 42 current members, whose strategy is<br>to explore example diseases, using a holistic, multi-<br>disciplinary approach, which could then be applied to<br>other conditions. Among health problems of current<br>interest to Forum members are Ehlers-Danlos<br>syndrome//hyper mobility spectrum disorders,<br>porphyria, fibromyalgia, and eosinophilic disease of<br>the gastrointestinal tract.<br>The FPOD Advisory Forum aims to make a<br>measurable difference to the lives of forgotten<br>patients, by drawing attention to overlooked diseases,<br>ideas & initiatives benefitting  affected individuals.|
|---|---|---|
|Relationship with any related<br>parties|Para 1.51|St Gilesmedical Ltd - a science writing, health film,<br>medical education & research company: Scientific<br>Director Dr Steven Walker is a FPOD trustee. St<br>Gilesmedical provides some administrative support<br>for FPOD, on a voluntary basis.<br>St Gilesmedical has made an interest-free loan to<br>FPOD. The loan and its management is detailed in<br>the Financial Review section of this form.|
|Other|||



## **Reference and Administrative details** 

|Charity name|Forgotten Patients, Overlooked Diseases|
|---|---|
|Other name the charity uses|None|
|Registered charity number|1202442|
|Charity’s principal address|c/o Suite 616<br>The Shepherds Building<br>Charecroft Way<br>London W14 0EE|
|||





## **Names of the charity trustees who manage the charity** 

||**Trustee name**|**Office (if any)**|**Dates acted if not for**<br>**whole year**|**Name of person (or body)**<br>**entitled to appoint trustee**<br>**(if any)**|
|---|---|---|---|---|
|1 <br>2 <br>3 <br>4 <br>5|Adrian Tookman|Chair|Not applicable|Not applicable|
||Steven Walker|Secretary|Not applicable|Not applicable|
||Fiona Strathern<br>Lapraik||Not applicable|Not applicable|
||Richard Stevens||Not applicable|Not applicable|
||Jacques Tamin||Not applicable|Not applicable|



Corporate trustees – names of the directors at the date the report was approved 

**Director name** 

No corporate trustees 


Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|None|||





## **Funds held as custodian trustees on behalf of others** 

|Description of the assets<br>held in this capacity|No funds held as custodian trustees on behalf of others|
|---|---|
|Name and objects of the<br>charity on whose behalf the<br>assets are held and how this<br>falls within the custodian<br>charity’s objects|Not applicable|
|Details of arrangements for<br>safe custody and<br>segregation of such assets<br>from the charity’s own assets|Not applicable|



## **Additional information (optional)** 

**Names and addresses of advisers (Optional information)** 

**Type of Name Address adviser** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

Not applicable 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s) Full name(s)** Adrian Tookman **Position (eg** Chair **Secretary, Chair, etc)** 

**Date** 17.02.2025 



|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|**Forgotten Patients, Overlooked Diseases ** _(Registered Charity no. 1202442)_:Accounts for 22.3.23 -30.6.24|||
|---|---|---|---|---|---|---|---|---|---|
|||||||||||
|**INCOME**|||**£**|||**LIABILITIES**||**£**|**£**|
||MembershipFees||140|||StGilesmedical Ltd|Loan|1500||
||Just GivingDonations||103||||Conference expenditure *|3617||
||Other Donations||600|||||||
||Conference Tickets||524||||Partial repayment of loan||525|
||Loan from StGilesmedical   Ltd.||1500|||||||
|||||||**Total still owed to StGilesmedical Ltd**||**4592**||
|||**TOTAL**|**2867**|||||||
|||||||||||
|**EXPENDITURE**||||||||||
||Conference|||||||||
|||Deposit(paid 11.10.23)^^|1105|||||||
|||Artwork(paid 11.10.23)^^|300|||||||
|||Accommodation(guest speakers)*|340|||||||
|||Balance of Delegate Package *|1575|||**Notes**||||
|||Room Hire with Laptop*|260|||* Payments made directlybySt Gilesmedical Ltd.||||
|||CPD Approval *|78|||actingas agent appointed byForgotten Patients,||||
|||Sound Engineer *|535|||Overlooked Diseases||||
|||Printing*|351|||^^ Payments made byForgotten Patients,||||
|||Name Badges *|15|||Overlooked Diseases(from StGilesMedical loan)||||
|||Advertising*|300|||||||
|||Sundries *|27|||||||
|||Travel *|61|||||||
|||Banners *|75|||||||
|||Charitylaunch event|500|||||||
||Testpayment||3|||||||
|||||||||||
|||**TOTAL**|**5525**|||||||



1 

